MSTR.NASDAQMicrostrategy INC
Form 4: MicroStrategy Director Stephen Graham Exercises Stock Options and Sells Shares
Sentiment:
SEC Form 4 Filing
Stephen Graham, a director at MicroStrategy, exercised stock options to acquire 2,000 shares of Class A common stock and sold 2,000 shares on February 28, 2024.
Summary
- On February 28, 2024, Stephen Graham, a director of MicroStrategy, exercised stock options to acquire 2,000 shares of Class A common stock at a price of $186.54 per share.
- On the same day, Graham sold 2,000 shares of Class A common stock at a price of $950 per share.
- Following these transactions, Graham directly owns 200 shares of Class A Common Stock.
- Graham also holds multiple director stock options to purchase MicroStrategy Class A common stock with various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider transactions. The exercise of options and sale of shares doesn't necessarily indicate a positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing Graham's transactions to other directors in similar tech companies is difficult without more data.
- However, the exercise of options and subsequent sale of shares is a common practice among executives to diversify their holdings and realize gains.
- The specific impact depends on the size of the transaction relative to Graham's total holdings and the overall trading volume of MSTR.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the selling pressure from the share sale.
- However, the overall impact is likely to be minimal given the size of the transactions relative to the company's market capitalization.
Key Dates
| Date | Description |
|---|---|
| May 31, 2018 | 1,250 shares of stock option vested with exercise price of $182.36 and expiration date of May 31, 2027. |
| May 31, 2019 | 750 shares vested from option exercised on 02/28/2024; 1,250 shares of stock option vested with exercise price of $182.36 and expiration date of May 31, 2027; 1,250 shares of stock option vested with exercise price of $129.57 and expiration date of May 31, 2028. |
| May 31, 2020 | 1,250 shares vested from option exercised on 02/28/2024; 1,250 shares of stock option vested with exercise price of $182.36 and expiration date of May 31, 2027; 1,250 shares of stock option vested with exercise price of $129.57 and expiration date of May 31, 2028; 1,250 shares of stock option vested with exercise price of $132.91 and expiration date of May 31, 2029. |
| May 31, 2021 | 1,250 shares of stock option vested with exercise price of $182.36 and expiration date of May 31, 2027; 1,250 shares of stock option vested with exercise price of $129.57 and expiration date of May 31, 2028; 1,250 shares of stock option vested with exercise price of $132.91 and expiration date of May 31, 2029; 1,250 shares of stock option vested with exercise price of $124.48 and expiration date of May 31, 2030. |
| May 31, 2022 | 1,250 shares of stock option vested with exercise price of $129.57 and expiration date of May 31, 2028; 1,250 shares of stock option vested with exercise price of $132.91 and expiration date of May 31, 2029; 1,250 shares of stock option vested with exercise price of $124.48 and expiration date of May 31, 2030; 1,250 shares of stock option vested with exercise price of $470.00 and expiration date of May 31, 2031. |
| May 31, 2023 | 1,250 shares of stock option vested with exercise price of $132.91 and expiration date of May 31, 2029; 1,250 shares of stock option vested with exercise price of $124.48 and expiration date of May 31, 2030; 1,250 shares of stock option vested with exercise price of $470.00 and expiration date of May 31, 2031; 1,250 shares of stock option vested with exercise price of $264.69 and expiration date of May 31, 2032. |
| February 28, 2024 | Stephen Graham exercised options for 2,000 shares at $186.54 each and sold 2,000 shares at $950 each. |
| May 31, 2024 | 1,250 shares of stock option are scheduled to vest with exercise price of $124.48 and expiration date of May 31, 2030; 1,250 shares of stock option are scheduled to vest with exercise price of $470.00 and expiration date of May 31, 2031; 1,250 shares of stock option are scheduled to vest with exercise price of $264.69 and expiration date of May 31, 2032; 761 shares of stock option are scheduled to vest with exercise price of $301.63 and expiration date of May 31, 2033; 497 restricted stock units are scheduled to vest. |
| May 31, 2025 | 1,250 shares of stock option are scheduled to vest with exercise price of $470.00 and expiration date of May 31, 2031; 1,250 shares of stock option are scheduled to vest with exercise price of $264.69 and expiration date of May 31, 2032. |
| May 31, 2026 | Expiration date of director stock option (Right to buy) $ 186.54 for 2,000 shares of Class A Common Stock; 1,250 shares of stock option are scheduled to vest with exercise price of $264.69 and expiration date of May 31, 2032. |
| May 31, 2027 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $182.36 per share. |
| May 31, 2028 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $129.57 per share. |
| May 31, 2029 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $132.91 per share. |
| May 31, 2030 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $124.48 per share. |
| May 31, 2031 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $470.00 per share. |
| May 31, 2032 | Expiration date of director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $264.69 per share. |
| May 31, 2033 | Expiration date of director stock option to purchase 761 shares of Class A common stock with an exercise price of $301.63 per share. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.